The recent opioid overdose-related death of Prince, a world-renowned musician, has once again put the spotlight on how overmedicated our society is and how desperately it is in need of an adjustment.
Last March, the Centers for Disease Control and Prevention shook the medical industry to its roots by encouraging doctors to use conservative care options prior to taking out the prescription pad for opioid use.
The move came in response to growing alarm over the most recent statistics, showing an annual toll of 28,647 deaths involving the potentially addictive drugs. The United States makes up only 4.6 percent of the world’s population, and yet consumes 80 percent of its opioids — and 99 percent of the world’s hydrocodone.
The most popular alternative approach, according to the Annals of Internal Medicine, is chiropractic care. And now the Foundation for Chiropractic Progress, the voice of the chiropractic profession, is out with a new white paper (“Chiropractic: A Safer Strategy Than Opioids”) that doesn’t stop at merely calling on prescribers to strictly follow the guidelines. Among the Foundation’s other recommendations:
• Establishing there is “more responsible marketing and physician education” on the part of the pharmaceutical manufacturers.
• Ensuring that chiropractic care is covered by all government and commercial insurance plans.
• Expanding chiropractic services to more veterans and active duty military members who are experiencing pain.
“The United States has awakened to the crushing impact of the opioid use/abuse epidemic,” says Sherry McAllister, DC, the Foundation’s executive vice president. Doctors of chiropractic, who have a minimum seven years of higher education, provide nonpharmaceutical care and conservative pain management to sufferers of neuro-musculoskeletal conditions, such as acute and chronic back and neck pain, as well as headaches. Numerous studies have shown chiropractic care yields improved patient outcomes, higher satisfaction and lower costs.
Learn more at F4CP.com.
Thanks: NewsUSA
Its time to think about Logo Designers, HURRY!!
Physician Prescribers Should Recommend Drug-Free Options Rather Than Opioids for Pain Relief
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the physician dispensed cosmeceuticals market include ALLERGAN, PhytogenX, Inc., BIOPELLE, INC, Clinique Laboratories, llc., IS CLINICAL, Jan Marini Skin Research, Inc., La Roche-Posay, Johnson & Johnson Consumer Inc., Obagi Cosmeceuticals LLC, Clarisonic, SkinCeuticals., Solta Medical, GlaxoSmithKline plc., ZO Skin Health.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Physician Dispensed Cosmeceuticals Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/physician-dispensed-cosmeceuticals-market/download-sampleMarket DynamicsThe significant growth in the demand for skincare and patients beginning to rely on dermatologists and cosmetic physicians to recommend suitable products for their skin, hair, and nails will be the main trending factors for physician-dispensed cosmeceuticals.
The rising levels of stress and pollution causing increased damage to the skin, hair, and eyes among the urban population will benefit market growth.
Various cosmetic startups specializing in the manufacture and marketing of cosmeceuticals, as advised by dermatologists, will positively impact the market.
The emergence of the novel concept of herbal medicine will boost the demand for organic physician dispensed cosmeceuticals.
We see that patients with Hashimoto's disease suffer from excess and sudden weight gain that they never imagined.
Their physician promised them to reduce their weight using medicines.
But their Hashimoto's disease weight loss strategy fails where their physician never asked them to make small lifestyle changes.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the physician dispensed cosmeceuticals market include ALLERGAN, PhytogenX, Inc., BIOPELLE, INC, Clinique Laboratories, llc., IS CLINICAL, Jan Marini Skin Research, Inc., La Roche-Posay, Johnson & Johnson Consumer Inc., Obagi Cosmeceuticals LLC, Clarisonic, SkinCeuticals., Solta Medical, GlaxoSmithKline plc., ZO Skin Health.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Physician Dispensed Cosmeceuticals Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/physician-dispensed-cosmeceuticals-market/download-sampleMarket DynamicsThe significant growth in the demand for skincare and patients beginning to rely on dermatologists and cosmetic physicians to recommend suitable products for their skin, hair, and nails will be the main trending factors for physician-dispensed cosmeceuticals.
The rising levels of stress and pollution causing increased damage to the skin, hair, and eyes among the urban population will benefit market growth.
Various cosmetic startups specializing in the manufacture and marketing of cosmeceuticals, as advised by dermatologists, will positively impact the market.
The emergence of the novel concept of herbal medicine will boost the demand for organic physician dispensed cosmeceuticals.
We see that patients with Hashimoto's disease suffer from excess and sudden weight gain that they never imagined.
Their physician promised them to reduce their weight using medicines.
But their Hashimoto's disease weight loss strategy fails where their physician never asked them to make small lifestyle changes.